ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Search by Abstract Number Results

  • Abstract Number: 0955 • ACR Convergence 2026

    A model to predict high-resolution manometry abnormalities in systemic sclerosis created using unbiased machine learning of chest computed tomography-derived esophageal parameters: a pilot study

    Mikito Suzuki1, Yuito Ueda2, Mita Sakuraba1, Yuichiro Shirai1, Takahisa Gono1, Noriyuki Kawami1, Masanori Atsukawa1, Hiroshi Takemura2 and Masataka Kuwana1 Affiliations: 1Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 2Tokyo University of Science, Chiba, Japan

    Background/Purpose: Esophageal involvement is a common manifestation of systemic sclerosis (SSc) and contributes to morbidity and impaired quality of life. Although high-resolution manometry (HRM) is…
  • Abstract Number: 0955 • ACR Convergence 2025

    Surveying RNA methylation in scleroderma highlights roles for demethylases ALKBH5 and FTO in fibrosis

    Alexander Cai1, Alyssa Rosek1, Neha Khanna1, Anna Webber1, Karly Kozicki1, Dinesh Khanna2 and Pei-Suen Tsou2, 1Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA, Ann Arbor, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: Recent studies indicate that genes involved in RNA methylation may play a significant role in cellular functions, and disruptions in RNA methylation have been…
  • Abstract Number: 0955 • ACR Convergence 2024

    Inhibition of Interleukin-2-Inducible T Cell Kinase with Soquelitinib Demonstrates Efficacy in Preventing Lung Damage in Murine Models of Systemic Sclerosis

    Goncalo Boleto1, Anne Cauvet2, James Rose3, Lih-Yun Hsu3, Richard A. Miller3 and Yannick Allanore4, 1Rheumatology Department, Unidade Local de Saúde Santa Maria, Centro Académico de Medicina de Lisboa, Lisboa, Portugal., Lisbon, Portugal, 2Université de Paris, Institut Cochin, INSERM U1016 CNRS UMR8104, Paris, France, 3Corvus Pharmaceuticals, 863 Mitten Road, Burlingame, Burlingame, CA, 4Université Paris Cité, Paris, France

    Background/Purpose: T cells abnormal activation plays a pivotal role in the early inflammatory stages of systemic sclerosis (SSc). Compelling evidence supports that SSc has a…
  • Abstract Number: 0955 • ACR Convergence 2023

    GRB2 Serves as a Viable Target Against Skin Fibrosis in Systemic Sclerosis by Regulating Endothelial Cell Apoptosis

    Yan Huang, Han Zhao, Xiangguang Shi, Jing Liu, Jui-Ming Lin, Qianqian Ma, Shuai Jiang, Weilin Pu, Yanyun Ma, Jianlan Liu, Wenyu Wu, Jiucun Wang and Qingmei Liu, Shanghai, Shanghai, China

    Background/Purpose: Systemic Sclerosis (SSc) is an autoimmune disease characterized by vascular and immune system dysfunction, along with tissue fibrosis. Vascular damage has been recognized as…
  • Abstract Number: 0955 • ACR Convergence 2022

    Unfavorable Pregnancy Outcome Is Significantly Associated with Corticosteroid Exposure During Pregnancy in Women with RA: Analysis of the Prospective GR2 Cohort

    SABRINA HAMROUN1, Marion Couderc2, Rene-Marc Flipo3, Laure Gossec4, Christophe Richez5, Rakiba Belkhir6, Aline Frazier-Mironer7, Valerie Devauchelle8, Hubert Marotte9, Jérémie SELLAM10, elisabeth gervais11, Alban DEROUX12, Cédric Lukas13, Emmanuelle Dernis14, Emmanuel Chatelus15 and Anna Molto16, 1Rheumatology Department, University Hospital of Cochin, Paris, Paris, France, 2University Hospital, Clermont-Ferrand, France, 3CHU Lille, Boulogne-Billancourt, France, 4Sorbonne Université, Paris, France, 5Université de Bordeaux, Bordeaux, France, 6Rheumatology departement, Bicêtre, Paris-Saclay university, Le Kremlin Bicêtre, France, 7APHP Hôpital Lariboisire, Paris, France, 8Université de Bretagne Occidentale, Brest, France, 9INSERM 1059, Saint-Etienne, France, 10Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France, 11chu poitiers, Poitiers, France, 12CHU Grenoble, Grenoble, France, 13University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 14LE MANS general hospital, LE MANS, France, 15University Hospital of Strasbourg, Strasbourg, France, 16Rheumatology Department, Cochin Hospital, APHP, Paris, France

    Background/Purpose: Rheumatoid arthritis (RA) is one of the most common chronic inflammatory diseases and regularly affects women of childbearing age. However, there is limited knowledge…
  • Abstract Number: 0955 • ACR Convergence 2021

    The Effect of Treatment with the Complement C5a Receptor Inhibitor Avacopan on Health-Related Quality of Life in ANCA-Associated Vasculitis

    Vibeke Strand1, Pirow Bekker2, Huibin Yue2, David R.W. Jayne3 and Peter Merkel4, 1Stanford University School of Medicine, Portola Valley, CA, 2ChemoCentryx, San Carlos, CA, 3University of Cambridge, Cambridge, United Kingdom, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Avacopan, an oral C5a receptor inhibitor, was evaluated in ANCA-associated vasculitis (AAV). Efficacy and safety results were reported previously. Health-related quality of life (HRQoL)…
  • Abstract Number: 0955 • ACR Convergence 2020

    Efficacy and Safety of IVIg (Octagam 10%) in Patients with Active Dermatomyositis. Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial (ProDERM Study)

    Rohit Aggarwal1, Christina Charles-Schoeman2, Joachim Schessl3, Zsuzsanna Bata-Csorgo4, Mazen Dimachkie5, Zoltan Griger6, Sergey Moiseev7, Chester Oddis8, Elena Schiopu9, Jiří Vencovský10, Beckmann Irene11, Clodi Elisabeth11, Todd Levine12 and and the ProDERM Investigators13, 1University of Pittsburgh, Pittsburgh, PA, 2University of California, Los Angeles, Los Angeles, CA, 3Städtisches Klinikum Karlsruhe, Karlsruhe, Germany, 4University of Szeged, Faculty of Medicine, Szeged, Hungary, 5Univeristy of Kansas, Medical Center, Kansas City, KS, 6University of Debrecen, Debrecen, Hungary, 7First Moscow State Medical University, Moscow, Russia, 8Department of Medicine, Division of Rheumatology, University of Pittsburgh, Pittsburgh, PA, 9Michigan Medicine, Ann Arbor, MI, 10Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 11Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria, 12Phoenix Neurological Associates, LTD, Phoenix, AZ, 13Different Institutions in several countries, Vienna, Austria

    Background/Purpose: Dermatomyositis (DM) is a rare chronic systemic autoimmune disease with characteristic skin rash and progressive proximal muscle weakness. Intravenous immunoglobulin (IVIg) has long been…
Search Again

Didn't find what you were looking for? Try the Advanced Search.

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology